中国の神経血管デバイス / インターベンショナル神経学市場

出版：Inkwood Research

CHINA NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028
中国の神経血管デバイス / インターベンショナル神経学市場

–

このレポートへお問合せ　　　レポート目次

Inkwood Research「CHINA NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST」は中国の神経血管デバイス / インターベンショナル神経学市場を分析・予測した市場調査レポートです。

KEY FINDINGS
The China neurovascular devices / interventional neurology market is estimated to record a CAGR of 5.22% during the forecast period, 2021-2026. The surging elderly population and the increasing R&D activities in neuro therapies are the key factors driving the market growth.
MARKET INSIGHTS
The increasing aging population contributes to the prevalence of dementia in the rural and semi-urban provinces of the country. As per the World Bank data, the country is the largest globally with regard to population, influencing Alzheimer’s prevalence.
Further, the country faces the greatest challenge of stroke. Approximately 2 million cases are registered every year. The growing incidences of stroke have led to increased awareness. The government is involved in spreading the knowledge and providing enhanced treatment, healthcare coverage, and medical technology. Moreover, China is investing more in the prevention and treatment of non-communicable diseases. Furthermore, the government has standardized the advanced techniques for stroke prevention and treatment for physicians across the country. Such factors are set to propel market growth in China.
COMPETITIVE INSIGHTS
Some of the leading companies in the market include Kaneka Corporation, Microport Scientific Corporation, Terumo Medical Corporation (Microvention Inc), B Braun Melsungen AG, Medtronic Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRY
3.3.5. INDUSTRY RIVALRY
3.4. OPPORTUNITY MATRIX
3.5. VENDOR LANDSCAPE
4. MARKET BY PRODUCT
4.1. EMBOLIZATION DEVICES
4.2. ACCESSORY DEVICES
4.3. REVASCULARIZATION DEVICES
4.4. THROMBECTOMY DEVICES
4.5. EMBOLIC PROTECTION DEVICES
5. MARKET BY APPLICATION
5.1. ANEURYSM
5.2. ISCHEMIC STROKE
5.3. STENOSIS
5.4. ARTERIOVENOUS MALFORMATION (AVM)
5.5. OTHER APPLICATIONS
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIC DEVELOPMENTS
6.1.1. MERGERS & ACQUISITIONS
6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
6.1.3. PARTNERSHIPS & AGREEMENTS
6.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
6.2. COMPANY PROFILES
6.2.1. B BRAUN MELSUNGEN AG
6.2.2. KANEKA CORPORATION
6.2.3. MEDTRONIC INC
6.2.4. MICROPORT SCIENTIFIC CORPORATION
6.2.5. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES
TABLE 2: CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: CHINA NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: CHINA NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: LEADING PLAYERS OPERATING IN CHINA NEUROVASCULAR DEVICES MARKET
TABLE 7: LIST OF MERGERS & ACQUISITIONS
TABLE 8: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 9: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 10: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

List of Figures

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020
FIGURE 6: CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2026 (IN $ MILLION)
FIGURE 7: CHINA NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2026 (IN $ MILLION)
FIGURE 8: CHINA NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2026 (IN $ MILLION)
FIGURE 9: CHINA NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2026 (IN $ MILLION)
FIGURE 10: CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2026 (IN $ MILLION)
FIGURE 11: CHINA NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020
FIGURE 12: CHINA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2026 (IN $ MILLION)
FIGURE 13: CHINA NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2026 (IN $ MILLION)
FIGURE 14: CHINA NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2026 (IN $ MILLION)
FIGURE 15: CHINA NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2026 (IN $ MILLION)
FIGURE 16: CHINA NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)

お問合せフォーム